NO20022122L - Omvendtfase HPLC-analyse for plasminogenaktivatorer - Google Patents

Omvendtfase HPLC-analyse for plasminogenaktivatorer

Info

Publication number
NO20022122L
NO20022122L NO20022122A NO20022122A NO20022122L NO 20022122 L NO20022122 L NO 20022122L NO 20022122 A NO20022122 A NO 20022122A NO 20022122 A NO20022122 A NO 20022122A NO 20022122 L NO20022122 L NO 20022122L
Authority
NO
Norway
Prior art keywords
sample
tpa
reverse phase
endogenous
phase hplc
Prior art date
Application number
NO20022122A
Other languages
English (en)
Other versions
NO329876B1 (no
NO20022122D0 (no
Inventor
Yuan Xu
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO20022122D0 publication Critical patent/NO20022122D0/no
Publication of NO20022122L publication Critical patent/NO20022122L/no
Publication of NO329876B1 publication Critical patent/NO329876B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Glass Compositions (AREA)
NO20022122A 1999-11-04 2002-05-03 Fremgangsmate for overvaking av effektiviteten til en renseprosess ved fjerning av endogen plasminogenaktivator (PA) fra kinesisk hamsterovarie-(CHO)-celler, fra en prove som inneholder human tPA eller et tPA-molekyl hvori Thr103 fra human villtype-tPA er endret til Asn, Asn117 fra human villtype-tPA er endret til Gln og Lys-His-Arg-Arg fra human villype-tPA er endret til Ala-Ala-Ala-Ala i posisjon 296-299 NO329876B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16360799P 1999-11-04 1999-11-04
PCT/US2000/030252 WO2001032915A2 (en) 1999-11-04 2000-11-01 Reversed-phase hplc assay for plasminogen activators

Publications (3)

Publication Number Publication Date
NO20022122D0 NO20022122D0 (no) 2002-05-03
NO20022122L true NO20022122L (no) 2002-07-03
NO329876B1 NO329876B1 (no) 2011-01-17

Family

ID=22590762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022122A NO329876B1 (no) 1999-11-04 2002-05-03 Fremgangsmate for overvaking av effektiviteten til en renseprosess ved fjerning av endogen plasminogenaktivator (PA) fra kinesisk hamsterovarie-(CHO)-celler, fra en prove som inneholder human tPA eller et tPA-molekyl hvori Thr103 fra human villtype-tPA er endret til Asn, Asn117 fra human villtype-tPA er endret til Gln og Lys-His-Arg-Arg fra human villype-tPA er endret til Ala-Ala-Ala-Ala i posisjon 296-299

Country Status (24)

Country Link
US (2) US6593097B1 (no)
EP (1) EP1226269B1 (no)
JP (1) JP4659320B2 (no)
KR (1) KR100649043B1 (no)
CN (1) CN1167808C (no)
AT (1) ATE243263T1 (no)
AU (1) AU781023B2 (no)
BR (1) BRPI0015283B8 (no)
CA (1) CA2384756C (no)
CZ (1) CZ302023B6 (no)
DE (1) DE60003449T2 (no)
DK (1) DK1226269T3 (no)
ES (1) ES2200973T3 (no)
HK (1) HK1046158B (no)
HU (1) HU226202B1 (no)
IL (1) IL149006A0 (no)
MX (1) MXPA02004401A (no)
NO (1) NO329876B1 (no)
NZ (1) NZ518187A (no)
PL (1) PL204011B1 (no)
PT (1) PT1226269E (no)
SI (1) SI1226269T1 (no)
WO (1) WO2001032915A2 (no)
ZA (1) ZA200202687B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU785483B2 (en) 1999-12-10 2007-09-20 Invitrogen Corporation Use of multiple recombination sites with unique specificity in recombinational cloning
EP2105496B1 (en) 2000-12-08 2013-02-20 Life Technologies Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6972327B1 (en) * 2001-05-08 2005-12-06 Immunex Corporation Regeneration of chromatography material
JP5148484B2 (ja) * 2005-05-24 2013-02-20 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ クロマトグラフィーマトリックスの再生
KR100701265B1 (ko) * 2006-01-16 2007-04-02 대한민국 재조합 사람 조직형 플라스미노겐 활성인자 발현벡터 및 플라스미노겐 활성인자를 소변으로 분비하는 형질전환돼지 생산방법
ES2764222T3 (es) * 2006-09-08 2020-06-02 Wyeth Llc Lavado con arginina en la purificación de proteínas mediante el uso de cromatografía de afinidad
EP2402752A3 (en) * 2006-10-27 2012-06-06 Janssen Pharmaceutica, N.V. A method for pharmacologically profiling compounds
CN101539550B (zh) * 2009-04-28 2012-05-23 李绍平 用于多糖的定性与定量分析方法
EP3592858B1 (en) 2017-03-09 2024-06-12 Universität des Saarlandes Means and methods for lignin pyrolysis
CN108333281A (zh) * 2018-02-08 2018-07-27 吉林大学 一种测定重组人粒细胞集落刺激因子二硫键组成的方法
CN108918749B (zh) * 2018-07-17 2020-05-05 北京赛升药业股份有限公司 一种蛇毒纤溶酶的反相hplc检测方法
CN114426962B (zh) * 2021-12-21 2024-06-18 佛山汉腾生物科技有限公司 t-PA纯化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484L (fi) 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
US4766075A (en) 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
US5120535A (en) * 1986-11-26 1992-06-09 Oncogen Oncostatin M and novel compositions having anti-neoplastic activity
US5411864A (en) * 1987-11-05 1995-05-02 Genentech, Inc. Method of purifying recombinant proteins from corresponding host cell proteins
GB8919803D0 (en) * 1989-09-01 1989-10-18 Ciba Geigy Pharmaceutical compositions
AU664469B2 (en) 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US5753702A (en) * 1996-05-22 1998-05-19 University Of Vermont Arachidonic acid metabolite, 16-hete

Also Published As

Publication number Publication date
HU226202B1 (en) 2008-06-30
HK1046158B (zh) 2003-11-28
US6593097B1 (en) 2003-07-15
KR20020070431A (ko) 2002-09-09
BRPI0015283A (pt) 2002-07-02
CA2384756A1 (en) 2001-05-10
HK1046158A1 (en) 2002-12-27
DE60003449D1 (de) 2003-07-24
NO329876B1 (no) 2011-01-17
AU1581601A (en) 2001-05-14
US20030199016A1 (en) 2003-10-23
KR100649043B1 (ko) 2006-11-27
CN1167808C (zh) 2004-09-22
PT1226269E (pt) 2003-11-28
AU781023B2 (en) 2005-04-28
ZA200202687B (en) 2003-06-25
BRPI0015283B1 (pt) 2015-03-17
IL149006A0 (en) 2002-11-10
PL204011B1 (pl) 2009-12-31
JP2003513638A (ja) 2003-04-15
HUP0202973A3 (en) 2005-11-28
MXPA02004401A (es) 2002-09-02
DK1226269T3 (da) 2003-10-13
US6828118B2 (en) 2004-12-07
JP4659320B2 (ja) 2011-03-30
ATE243263T1 (de) 2003-07-15
CA2384756C (en) 2010-09-28
ES2200973T3 (es) 2004-03-16
BRPI0015283B8 (pt) 2021-07-06
PL355389A1 (en) 2004-04-19
NZ518187A (en) 2002-12-20
WO2001032915A3 (en) 2002-03-07
NO20022122D0 (no) 2002-05-03
SI1226269T1 (en) 2003-12-31
EP1226269B1 (en) 2003-06-18
HUP0202973A2 (hu) 2002-12-28
DE60003449T2 (de) 2004-05-06
CN1387579A (zh) 2002-12-25
EP1226269A2 (en) 2002-07-31
CZ20021196A3 (cs) 2002-08-14
WO2001032915A2 (en) 2001-05-10
CZ302023B6 (cs) 2010-09-08

Similar Documents

Publication Publication Date Title
NO20022122L (no) Omvendtfase HPLC-analyse for plasminogenaktivatorer
Walker Regulation of activated protein C by a new protein. A possible function for bovine protein S.
Church et al. Rapid sulfopropyl-disk chromatographic purification of bovine and human thrombin
McClure et al. Post-translational processing events in the secretion pathway of human protein C, a complex vitamin K-dependent antithrombotic factor.
Liebman Isolation and characterization of a hepatoma-associated abnormal (des-γ-carboxy) prothrombin
Sekimoto et al. Biochemical and physiological properties of a protein inducing protoplast release during conjugation in the Closterium peracerosum-strigosum-littorale complex
Iwata et al. Purification, identification, and characterization of elastase on erythrocyte membrane as factor IX-activating enzyme
Wiman et al. Amino‐Acid Sequence of the Cyanogen‐Bromide Fragment from Human Plasminogen that Forms the Linkage between the Plasmin Chains
US4229540A (en) Hydrolase purified from human plasma
Khan et al. Biochemical characterization of a factor X activator protein purified from Walterinnesia aegyptia venom
Iijima et al. A new hereditary abnormal protein C (protein C Yonago) with a dysfunctional Gla-domain
Horne III et al. Comparison of the effect of histidine-rich glycoprotein and 6-aminohexanoic acid on plasmin production and fibrinolysis in vitro
Tanaka et al. High-molecular-weight renin converting enzyme from dog kidney: detection and fractionation
Cohen et al. Partial purification and characterization of the high molecular weight latent collagenase from human leukocytes
Soeda et al. Assay of Arginine-Esterase Activities by Reversed Phase High Performance Liquid Chromatography
Liebman Isolation and Characterization of a Hepatoma-associated Abnormal (Des-7-carboxy) prothrombin1
Kentzer et al. Characterization of plasmin digested peptide maps for recombinant high molecular weight urokinase and pro-Urokinase. Its use for the estimation of low molecular weight urokinase in pro-UK/HMW-UK

Legal Events

Date Code Title Description
MK1K Patent expired